Days Inventory is also known as Days Sales of Inventory (DSI). Bod Science's Average Total Inventories for the
six
months ended in Jun. 2025 was A$0.38 Mil. Bod Science's Cost of Goods Sold for the
six
months ended in Jun. 2025 was A$0.75 Mil.
Hence, Bod Science's Days Inventory for the
six
months ended in Jun. 2025 was 91.74.
The historical rank and industry rank for Bod Science's Days Inventory or its related term are showing as below:
ASX:BOD'
s Days Inventory Range Over the Past 10 Years
Min: 39.51 Med: 171.68 Max: 641.41
Current: 150.94
During the past 9 years, Bod Science's highest Days Inventory was 641.41. The lowest was 39.51. And the median was 171.68.
ASX:BOD's Days Inventory is not ranked
in the Drug Manufacturers industry.
Industry Median: 164.48
vs ASX:BOD: 150.94
Bod Science's Days Inventory
declined
from Jun. 2024 (374.72) to Jun. 2025 (91.74).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bod Science's Inventory Turnover for the
six
months ended in Jun. 2025 was 1.99.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bod Science's Inventory-to-Revenue for the
six
months ended in Jun. 2025 was 0.43.
Bod Science (ASX:BOD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bod Science's Inventory Turnover for the
six
months ended in Jun. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bod Science's Inventory to Revenue for the
six
months ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bod Science Days Inventory Related Terms
Bod Science Days Inventory Historical Data
* Premium members only.
The historical data trend for Bod Science's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bod Science's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bod Science Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bod Science's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bod Science's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bod Science (ASX:BOD) has a Days Inventory of 91.74 as of Jun. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bod Science and its competitors. This is 47% below median its historical median of 171.68. Over the past decade, Bod Science's Days Inventory has ranged from 39.51 to 641.41.
Is Bod Science's Days Inventory too high?
Bod Science's current Days Inventory of 91.74 is 47% below median its 10-year median of 171.68. Over the past 10 years, this metric has ranged from a low of 39.51 to a high of 641.41. The Drug Manufacturers industry median Days Inventory is 164.48. Bod Science's value of 91.74 is 44.2% below this industry median. Overall, Bod Science has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bod Science's Days Inventory compare to ZTS?
Bod Science's Days Inventory of 91.74 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.48. Bod Science's value of 91.74 is 44.2% below this benchmark. Historically, Bod Science's own Days Inventory has ranged from 39.51 to 641.41 over the past decade. While the company's 10-year median is 171.68 vs. the industry median of 164.48, Bod Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bod Science's current Days Inventory of 91.74 is 44.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bod Science and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bod Science's current Days Inventory is 91.74, which is 47% below median its own 10-year median of 171.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bod Science stock overvalued right now?
Bod Science (ASX:BOD) has a current Days Inventory of 91.74. The stock's GF Value™ is A$0.04, compared to a current price of A$0.02 — trading 40% below its estimated fair value. The current Days Inventory is 91.74, which is 47% below median its 10-year median of 171.68 and 44.2% below the Drug Manufacturers industry median of 164.48. Bod Science's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bod Science (ASX:BOD), the current Days Inventory is 91.74 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bod Science (ASX:BOD) Overvalued in 2026?
Based on GuruFocus' analysis, Bod Science stock appears to be undervalued.
The current stock price of A$0.02 is trading 40% below its estimated GF Value™ of A$0.04.
Key valuation signals for ASX:BOD:
Days Inventory: 91.74 (47% below median its 10-year median of 171.68)
GF Value™: A$0.04 vs. price of A$0.02 (40% below fair value)
Industry Position: 44.2% below the Drug Manufacturers median
No single metric tells the full story. See the ASX:BOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bod Science Ltd is a healthcare company combining the power of nature and science to deliver cannabis-derived health and skincare products, designed to improve lives and transform the medicinal cannabis, CBD, and hemp market. The firm is focused on cannabis drug development and products. The company is focused on progressing Research and Development and a defined clinical trial pathway to commercialize and deliver premium, scientifically trusted products for the consumer and medical markets. It earned it profits and sales revenue from Australia even though have segment in UK, Europe and USA.
12GF Score
Get the complete analysis for ASX:BOD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BOD has been successfully added to your 
